Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Efp: A ring of independence?

Breast cancer patients who respond to tamoxifen and other estrogen-antagonizing drugs can succumb to disease when cancer growth becomes independent of the hormone. One protein, Efp, that might have a role in estrogen independence has now been linked to proteolytic events in the cell cycle.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The estrogen-inducible RING finger protein Efp stimulates proliferation of breast cancer cells.

References

  1. Urano, T. et al. Estrogen-responsive RING finger protein efp targets 13-3-3σ ubiquitination and promotes tumor growth of breast cancer. Nature 417, 871–875 (2002).

    Article  CAS  Google Scholar 

  2. The ubiquitin system. Hershko, A. & Ciechanover, A. Annu. Rev. Biochem. 67, 425–479 (1998).

    Article  CAS  Google Scholar 

  3. Koepp, D.M., Harper, J.W. & Elledge, S.J. How the cyclin became a cyclin: Regulated proteolysis in the cell cycle. Cell 97, 431–434 (1999).

    Article  CAS  Google Scholar 

  4. Joazeiro, C.A. & Weissman, A.M. . RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102, 549–552 (2000).

    Article  CAS  Google Scholar 

  5. Jackson, P.K., Eldridge, A.G., Freed, E, Furstenthal L., Hsu, J.Y., Kaiser. B.K., & Reimann, J.D. The lore of the RINGs: Substrate recognition and catalysis by ubiquitin ligases. Trends Cell. Biol. 10, 429–439 (2000).

    Article  CAS  Google Scholar 

  6. McKenna, N.J. & O'Malley, B.W. An issue of tissues: Divining the split personalities of selective estrogen receptor modulators. Nature Med. 6, 960–962 (2000).

    Article  CAS  Google Scholar 

  7. Hermeking H. et al. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3–11 (1997).

    Article  CAS  Google Scholar 

  8. Chan, T.A., et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616–620 (1999).

    Article  CAS  Google Scholar 

  9. Gasco, M. et al. Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21, 1876–1881 (2002).

    Article  CAS  Google Scholar 

  10. Gasco, M. et al. Epigenetic inactivation of 14-3-3σ in oral carcinoma: Association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res. 62, 2072–2076 (2002).

    CAS  Google Scholar 

  11. Ikeda, K., Orimo, A., Higashi, Y., Muramatsu, M. & Inoue, S. Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett. 472, 9–13 (2000).

    Article  CAS  Google Scholar 

  12. Thomson, S.D. et al. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast. Int. J. Cancer 91, 152–158 (2001).

    Article  CAS  Google Scholar 

  13. Hondermarck, H. et al. Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 1, 1216–1232 (2001).

    Article  CAS  Google Scholar 

  14. Chan, T.A., Hwang P.M., Hermeking H., Kinzler K.W. & Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14, 1584–1588 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nalepa, G., Harper, J. Efp: A ring of independence?. Nat Med 8, 661–662 (2002). https://doi.org/10.1038/nm0702-661

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0702-661

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing